The identification of rare PVs in genes beyond COL1A1 and COL1A2 has challenged the traditional view of OI as a monogenic disorder and has led to a better understanding of the underlying molecular mechanisms and clinical heterogeneity (3, 4). Here, COL1A2 is linked to osteogenesis imperfecta.